Cargando…

SUN-532 Interferon Gamma-1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant Osteopetrosis

In autosomal dominant osteopetrosis type 2 (ADO2) CLCN7 mutations cause impaired osteoclast function. Severe consequences include skeletal fragility despite high bone mass, osteomyelitis, osteonecrosis, bone marrow failure, and severe cranial nerve impingement. There is no effective medical treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imel, Erik, Liu, Ziyue, Acton, Dena, Coffman, Melissa, Gebregziabher, Netsanet, Tong, Yan, Econs, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552866/ http://dx.doi.org/10.1210/js.2019-SUN-532

Ejemplares similares

SUN-526 Prevalence of Hyperparathyroidism in X-Linked Hypophosphatemia
por: DeLacey, Sean, et al.
Publicado: (2019)

SUN-521 Intracranial Calcifications Outside the Basal Ganglia at Presentation of Barakat Syndrome
por: Aguirre, Rebecca, et al.
Publicado: (2019)

Osteopetrosis - A Case Series Exploring Complications and Multidisciplinary Management
por: Stewart, Catherine, et al.
Publicado: (2021)

OR13-3 Effects of Iron Isomaltoside versus Ferric Carboxymaltose on Hormonal Control of Phosphate Homeostasis: The PHOSPHARE-IDA04/05 Randomized Controlled Trials
por: Wolf, Myles, et al.
Publicado: (2019)

SUN-356 Burosumab Resulted in Greater Clinical Improvements Compared with Higher-dose Conventional Therapy in Children with X-linked Hypophosphatemia (XLH)
por: Imel, Erik A, et al.
Publicado: (2020)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

SUN-347 Glucagon-like Peptide 1 (GLP-1) Acts Directly On Human Osteoclasts To Increase Differentiation And Bone Resorptive Activity
por: Hansen, Morten Steen, et al.
Publicado: (2020)

Delayed Diagnosis of Congenital Hypoparathyroidism in a Kindred of Three Patients With Autosomal Dominant Deafness
por: Dandurand, Karel, et al.
Publicado: (2021)

RF30 | PSAT134 Autosomal Dominant Hereditary Multiple Osteochondromas Misdiagnosed As Paget's Disease of Bone
por: Myers, Kyle, et al.
Publicado: (2022)

SAT218 Refractory Hypocalcemia From Combined Autosomal Dominant Hypocalcemia Type 2 And Postsurgical Hypoparathyroidism
por: Sonmez Ince, Melda, et al.
Publicado: (2023)

SAT-347 Diagnosis of Autosomal Dominant Hypocalcemia Type 1 Following the Initiation of Imatinib for Treatment of Chronic Myeloid Leukemia
por: Jones-Ryan, Madeline L, et al.
Publicado: (2020)

SUN-517 Postoperative Hypoparathyroidism Treated With Teriparatide In Apatient With Malabsorption Due To Celiac Disease: A Case Report And Literature Review
por: Khan, Mehr, et al.
Publicado: (2019)

MON-532 Urinary Calcium Indices in Primary Hyperparathyroidism (PHPT) and Familial Hypocalciuric Hypercalcaemia (FHH): Is There a Need for Better Discrimination?
por: Arshad, Muhammad Fahad, et al.
Publicado: (2019)

SAT-351 A Novel Mutation in the Calcium-Sensing Receptor Gene Presenting in a Kindred as Autosomal Dominant Familial Hypocalciuric Hypercalcemia
por: Bushman, Jordan, et al.
Publicado: (2020)

A Phase 2B, Open-Label, Dose-Ranging Study of Encaleret (CLTX-305) in Autosomal Dominant Hypocalcemia Type 1 (ADH1)
por: Gafni, Rachel Ilana, et al.
Publicado: (2021)

OR21-2 Encaleret (CLTX-305) Restored Mineral Homeostasis in a Phase 2 Study in Autosomal Dominant Hypocalcemia Type 1 (ADH1)
por: Collins, Michael, et al.
Publicado: (2022)

SUN-490 Enigmatic Presentations Of Hyperparathyroidism
por: NAGAPRIYA, VELLALACHERUVU, et al.
Publicado: (2019)

SUN-505 The Invincible Parathyroid Gland
por: Mayorga, Mabel, et al.
Publicado: (2019)

SUN-502 From Pseudohypoparathyroidism to Signaling Disorder
por: Imam, Ahmad, et al.
Publicado: (2019)

SUN-491 An Uncommon Presentation of Primary Hiperparathyroidism
por: Bastos, Filipa, et al.
Publicado: (2019)

OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
por: Arlt, Heike, et al.
Publicado: (2019)

OR23-03 Sustained Normalization Of Mineral Homeostasis In Autosomal Dominant Hypocalcemia Type 1: Results From A Phase 2 Study Over 18 Months Of Encaleret (CLTX-305) Treatment (NCT04581629)
por: Ilana Gafni, Rachel, et al.
Publicado: (2023)

SUN-LB67 Revisit Serum Calcium Correction
por: Li, Yulong, et al.
Publicado: (2020)

SUN-349 Characterizing Functional Performance in Adults with Hypophosphatasia
por: Dahir, Kathryn, et al.
Publicado: (2020)

SUN-519 Hypoparathyroidism after Harvoni Treatment for Hepatitis C
por: Sajja, Puspalatha, et al.
Publicado: (2019)

SUN-544 A Not-So-Poetic Case of Abdominal Distension
por: Ellard, Karolina, et al.
Publicado: (2019)

SUN-516 Fahr's Syndrome: A Rare Sequela of Hypoparathyroidism
por: Min, Lei Lei, et al.
Publicado: (2019)

SUN-525 Burosumab Experience In A UK Adolescent Population
por: Dharmaraj, Poonam, et al.
Publicado: (2019)

SUN-506 An Interesting Case Of Low-Grade Parathyroid Carcinoma
por: Mundada, Rachana, et al.
Publicado: (2019)

SUN-531 Screening for Coexisting Diseases in Patients with Fibrous Dysplasia
por: Huma, Zilla, et al.
Publicado: (2019)

SUN-492 Unresolved Hyperparathyroidism Due To Mediastinal Parathyroid Adenoma
por: Brown, Isaiah, et al.
Publicado: (2019)

SUN-495 Resolution of Hypocalcemia during Pregnancy in Chronic Hypoparathyroidism
por: Regeti, Kalyani, et al.
Publicado: (2019)

SUN-391 Denosumab Treatment of Patients with Osteoporosis and Idiopathic Hypercalciuria
por: Chu, Winston S, et al.
Publicado: (2020)

SUN-382 Craniopharyngioma Patients Are at Risk of Impaired Bone Health
por: van Santen, Selveta Sanne
Publicado: (2020)

SUN-393 The Impact of Micronutrients on Cellular Metabolism and Healthy Aging
por: Astrup, Arne, et al.
Publicado: (2020)

SUN-LB64 Urine Phosphoethanolamine Is an Underutilized Biomarker for Hypophosphastasia
por: Shajani-Yi, Zahra, et al.
Publicado: (2020)

SUN-343 Prevalence and Incidence of Hypomagnesemia and Hypermagnesemia in Medical Settings
por: Catalano, Antonino, et al.
Publicado: (2020)

SUN-361 Cultured Murine Osteoblasts Convert DHEA to Testosterone
por: Clines, Katrina L, et al.
Publicado: (2020)

SUN-373 Addressing the Burden of Hip Fracture in Older Men
por: Khan, Mehreen, et al.
Publicado: (2020)

The Effects of Encaleret (CLTX-305) on Mineral Physiology in Autosomal Dominant Hypocalcemia Type 1 (ADH1) Demonstrate Proof-of-Concept: Early Results From an Ongoing Phase 2b, Open-Label, Dose-Ranging Study
por: Gafni, Rachel Ilana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j1bgo5omv5estvie0vp3fbs8ec